Current Status of Biosimilars and Their Impact on Pharmacovigilance

Posted on by admin
1 min read

As the market for biosimilars expands, a nuanced approach is needed to balance cost considerations with patient safety and pharmacovigilance efforts.

Avatar for admin
admin https://goorre.com

You May Also Like

More From Author

+ There are no comments

Add yours